New York State Common Retirement Fund Evelo Biosciences, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.46 - $3.55 $22,630 - $55,025	-15,500 Reduced 98.32%	265 $1,000
Q4 2021 Feb 02, 2022	BUY	$6.07 - $12.0 $35,066 - $69,324	5,777 Added 57.84%	15,765 $96,000
Q3 2021 Nov 02, 2021	SELL	$6.79 - $13.9 $117,487 - $240,511	-17,303 Reduced 63.4%	9,988 $70,000
Q2 2021 Aug 02, 2021	BUY	$9.43 - $16.6 $64,982 - $114,390	6,891 Added 33.78%	27,291 $375,000
Q1 2021 May 11, 2021	BUY	$9.71 - $18.6 $93,216 - $178,560	9,600 Added 88.89%	20,400 $218,000
Q1 2019 May 08, 2019	BUY	$7.5 - $15.31 $26,250 - $53,585	3,500 Added 47.95%	10,800 $86,000
Q2 2018 Aug 10, 2018	BUY	$11.39 - $16.26 $83,147 - $118,698	7,300 New	7,300 $86,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.